Literature DB >> 27807814

The European Network of Coloproctology: a strategy towards the European research and healthcare system.

Michele Rubbini1.   

Abstract

Many documents from the International Institutions point out that Health represents an engine of economic and social development. Based on these documents and concepts, the European Parliament decided to create a system of European Reference Networks as a synthesis of clinical and research activities, particularly in the field of rare diseases. This initiative, properly implemented, could be first step towards a new European health system. This article instead, wanting to deepen this perspective, postulates that the ERNs may also be related to widespread diseases, such as those of coloproctological interest, with the aim of setting up a European Network of Coloproctology (ENCP). Here are analyzed: (a) the documents related to ERNs and others related to research and training, the characteristics of the coloproctological diseases, and proposal of the ENCP; (b) a survey that involves 14 out of 25 of the National and Regional Representative of the European Society of Coloproctology. Hundred percent of the people interviewed agree to the ENCP project. The percentage of the approved proposed fields of activity of the ENCP are: Healthcare 71%, Research 100%, Training 86%, Support to legislation 78%, Professional Mobility 64%, Patient Database 71%, and Expenditure control 64%. From the analysis of the documents and the result of the survey, ERNs are appropriate not only in relation to rare diseases but also in those fields with higher diffusion and the creation of a European Network of Coloproctology is then postulated.

Entities:  

Keywords:  Colon and rectal surgery; Educational; European network; Research

Mesh:

Year:  2016        PMID: 27807814     DOI: 10.1007/s13304-016-0408-6

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  7 in total

1.  European Clinical Research Infrastructures Network: promoting harmonisation and quality in European clinical research.

Authors:  Jacques Demotes-Mainard; Christian Ohmann
Journal:  Lancet       Date:  2005 Jan 8-14       Impact factor: 79.321

2.  Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  B Glimelius; E Tiret; A Cervantes; D Arnold
Journal:  Ann Oncol       Date:  2013-10       Impact factor: 32.976

3.  Data Sharing at a Crossroads.

Authors:  Frank Rockhold; Perry Nisen; Andrew Freeman
Journal:  N Engl J Med       Date:  2016-09-22       Impact factor: 91.245

Review 4.  Cancer survival: global surveillance will stimulate health policy and improve equity.

Authors:  Michel P Coleman
Journal:  Lancet       Date:  2013-12-16       Impact factor: 79.321

5.  Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study.

Authors:  Roberta De Angelis; Milena Sant; Michel P Coleman; Silvia Francisci; Paolo Baili; Daniela Pierannunzio; Annalisa Trama; Otto Visser; Hermann Brenner; Eva Ardanaz; Magdalena Bielska-Lasota; Gerda Engholm; Alice Nennecke; Sabine Siesling; Franco Berrino; Riccardo Capocaccia
Journal:  Lancet Oncol       Date:  2013-12-05       Impact factor: 41.316

Review 6.  Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use.

Authors:  M J Duffy; A van Dalen; C Haglund; L Hansson; E Holinski-Feder; R Klapdor; R Lamerz; P Peltomaki; C Sturgeon; O Topolcan
Journal:  Eur J Cancer       Date:  2007-05-18       Impact factor: 9.162

7.  Factors influencing clinical trial site selection in Europe: the Survey of Attitudes towards Trial sites in Europe (the SAT-EU Study).

Authors:  Marta Gehring; Rod S Taylor; Marie Mellody; Brigitte Casteels; Angela Piazzi; Gianfranco Gensini; Giuseppe Ambrosio
Journal:  BMJ Open       Date:  2013-11-15       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.